1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Huang, Q. Yu, L. Petros, A.M. Gunasekera, A. Liu, Z. Xu, N. Hajduk, P. Mack, J. Fesik, S.W. Olejniczak, E.T. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 43 6059 6063 10.1021/bi036155b 15147189 Structure of the N-Terminal RNA-Binding Domain of the SARS CoV Nucleocapsid Protein. 2004 10.2210/pdb1ssk/pdb pdb_00001ssk 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 17179.035 Nucleocapsid protein N-terminal Domain 1 man polymer N structural protein, NC no no MGSSHHHHHHSSGLVPRGSAMGLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMK ELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGS MGSSHHHHHHSSGLVPRGSAMGLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMK ELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Coronavirus SARS Escherichia Escherichia coli sample N 227859 SARS coronavirus 511693 Escherichia coli BL21 BL21 plasmid pet21d+ database_2 pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2004-06-08 1 1 2008-04-29 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details RCSB Y RCSB 2004-03-24 REL 1 3D_13C-separated_NOESY 3D_15N-separated_NOESY 100mM Nacl 6.8 ambient 298 K simulated annealing 1 minimized average structure 0.5 mM N-terminal SARS CoV NP, U-15N,90% H2O/10% 2H2O, 50 mM sodium phosphate (pH 6.8) and 100 mM sodium chloride. brunger refinement CNS 2000 800 Bruker AVANCE 600 Bruker AVANCE 500 Bruker AVANCE MET 1 n 1 MET 1 A GLY 2 n 2 GLY 2 A SER 3 n 3 SER 3 A SER 4 n 4 SER 4 A HIS 5 n 5 HIS 5 A HIS 6 n 6 HIS 6 A HIS 7 n 7 HIS 7 A HIS 8 n 8 HIS 8 A HIS 9 n 9 HIS 9 A HIS 10 n 10 HIS 10 A SER 11 n 11 SER 11 A SER 12 n 12 SER 12 A GLY 13 n 13 GLY 13 A LEU 14 n 14 LEU 14 A VAL 15 n 15 VAL 15 A PRO 16 n 16 PRO 16 A ARG 17 n 17 ARG 17 A GLY 18 n 18 GLY 18 A SER 19 n 19 SER 19 A ALA 20 n 20 ALA 20 A MET 21 n 21 MET 21 A GLY 22 n 22 GLY 22 A LEU 23 n 23 LEU 23 A PRO 24 n 24 PRO 24 A ASN 25 n 25 ASN 25 A ASN 26 n 26 ASN 26 A THR 27 n 27 THR 27 A ALA 28 n 28 ALA 28 A SER 29 n 29 SER 29 A TRP 30 n 30 TRP 30 A PHE 31 n 31 PHE 31 A THR 32 n 32 THR 32 A ALA 33 n 33 ALA 33 A LEU 34 n 34 LEU 34 A THR 35 n 35 THR 35 A GLN 36 n 36 GLN 36 A HIS 37 n 37 HIS 37 A GLY 38 n 38 GLY 38 A LYS 39 n 39 LYS 39 A GLU 40 n 40 GLU 40 A GLU 41 n 41 GLU 41 A LEU 42 n 42 LEU 42 A ARG 43 n 43 ARG 43 A PHE 44 n 44 PHE 44 A PRO 45 n 45 PRO 45 A ARG 46 n 46 ARG 46 A GLY 47 n 47 GLY 47 A GLN 48 n 48 GLN 48 A GLY 49 n 49 GLY 49 A VAL 50 n 50 VAL 50 A PRO 51 n 51 PRO 51 A ILE 52 n 52 ILE 52 A ASN 53 n 53 ASN 53 A THR 54 n 54 THR 54 A ASN 55 n 55 ASN 55 A SER 56 n 56 SER 56 A GLY 57 n 57 GLY 57 A PRO 58 n 58 PRO 58 A ASP 59 n 59 ASP 59 A ASP 60 n 60 ASP 60 A GLN 61 n 61 GLN 61 A ILE 62 n 62 ILE 62 A GLY 63 n 63 GLY 63 A TYR 64 n 64 TYR 64 A TYR 65 n 65 TYR 65 A ARG 66 n 66 ARG 66 A ARG 67 n 67 ARG 67 A ALA 68 n 68 ALA 68 A THR 69 n 69 THR 69 A ARG 70 n 70 ARG 70 A ARG 71 n 71 ARG 71 A VAL 72 n 72 VAL 72 A ARG 73 n 73 ARG 73 A GLY 74 n 74 GLY 74 A GLY 75 n 75 GLY 75 A ASP 76 n 76 ASP 76 A GLY 77 n 77 GLY 77 A LYS 78 n 78 LYS 78 A MET 79 n 79 MET 79 A LYS 80 n 80 LYS 80 A GLU 81 n 81 GLU 81 A LEU 82 n 82 LEU 82 A SER 83 n 83 SER 83 A PRO 84 n 84 PRO 84 A ARG 85 n 85 ARG 85 A TRP 86 n 86 TRP 86 A TYR 87 n 87 TYR 87 A PHE 88 n 88 PHE 88 A TYR 89 n 89 TYR 89 A TYR 90 n 90 TYR 90 A LEU 91 n 91 LEU 91 A GLY 92 n 92 GLY 92 A THR 93 n 93 THR 93 A GLY 94 n 94 GLY 94 A PRO 95 n 95 PRO 95 A GLU 96 n 96 GLU 96 A ALA 97 n 97 ALA 97 A SER 98 n 98 SER 98 A LEU 99 n 99 LEU 99 A PRO 100 n 100 PRO 100 A TYR 101 n 101 TYR 101 A GLY 102 n 102 GLY 102 A ALA 103 n 103 ALA 103 A ASN 104 n 104 ASN 104 A LYS 105 n 105 LYS 105 A GLU 106 n 106 GLU 106 A GLY 107 n 107 GLY 107 A ILE 108 n 108 ILE 108 A VAL 109 n 109 VAL 109 A TRP 110 n 110 TRP 110 A VAL 111 n 111 VAL 111 A ALA 112 n 112 ALA 112 A THR 113 n 113 THR 113 A GLU 114 n 114 GLU 114 A GLY 115 n 115 GLY 115 A ALA 116 n 116 ALA 116 A LEU 117 n 117 LEU 117 A ASN 118 n 118 ASN 118 A THR 119 n 119 THR 119 A PRO 120 n 120 PRO 120 A LYS 121 n 121 LYS 121 A ASP 122 n 122 ASP 122 A HIS 123 n 123 HIS 123 A ILE 124 n 124 ILE 124 A GLY 125 n 125 GLY 125 A THR 126 n 126 THR 126 A ARG 127 n 127 ARG 127 A ASN 128 n 128 ASN 128 A PRO 129 n 129 PRO 129 A ASN 130 n 130 ASN 130 A ASN 131 n 131 ASN 131 A ASN 132 n 132 ASN 132 A ALA 133 n 133 ALA 133 A ALA 134 n 134 ALA 134 A THR 135 n 135 THR 135 A VAL 136 n 136 VAL 136 A LEU 137 n 137 LEU 137 A GLN 138 n 138 GLN 138 A LEU 139 n 139 LEU 139 A PRO 140 n 140 PRO 140 A GLN 141 n 141 GLN 141 A GLY 142 n 142 GLY 142 A THR 143 n 143 THR 143 A THR 144 n 144 THR 144 A LEU 145 n 145 LEU 145 A PRO 146 n 146 PRO 146 A LYS 147 n 147 LYS 147 A GLY 148 n 148 GLY 148 A PHE 149 n 149 PHE 149 A TYR 150 n 150 TYR 150 A ALA 151 n 151 ALA 151 A GLU 152 n 152 GLU 152 A GLY 153 n 153 GLY 153 A SER 154 n 154 SER 154 A ARG 155 n 155 ARG 155 A GLY 156 n 156 GLY 156 A GLY 157 n 157 GLY 157 A SER 158 n 158 SER 158 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 111 A O VAL 111 A N GLY 63 A N GLY 63 A N ALA 68 A N ALA 68 A O ARG 85 A O ARG 85 A O TRP 86 A O TRP 86 A N LEU 34 A N LEU 34 A N THR 35 A N THR 35 A O TYR 150 A O TYR 150 1 A SER 4 49.54 94.31 1 A HIS 7 -55.68 -176.69 1 A HIS 8 -67.77 73.70 1 A SER 11 73.72 40.45 1 A ARG 17 57.96 105.27 1 A MET 21 -59.42 -81.14 1 A ASN 26 -142.32 36.07 1 A SER 29 168.45 86.16 1 A PHE 31 168.58 -179.91 1 A ARG 43 171.74 76.78 1 A PRO 45 -52.40 173.40 1 A ARG 46 -64.10 -177.79 1 A GLN 48 -136.09 -56.28 1 A PRO 51 -48.64 177.75 1 A ASN 53 63.08 179.13 1 A ASN 55 -152.92 33.83 1 A SER 56 -97.76 36.85 1 A ASP 60 -150.55 54.14 1 A ARG 67 -52.34 106.66 1 A GLU 81 63.44 94.57 1 A THR 93 -149.07 -54.09 1 A PRO 95 -60.98 -149.74 1 A ALA 97 47.08 29.02 1 A LEU 99 -47.60 166.41 1 A TYR 101 61.61 74.25 1 A ALA 103 -64.66 80.24 1 A GLU 114 -68.40 70.76 1 A ASN 118 75.18 108.14 1 A LYS 121 169.86 83.85 1 A HIS 123 170.38 42.01 1 A PRO 129 -59.08 78.45 1 A ASN 130 167.45 -34.32 1 A ASN 131 -73.79 -70.32 1 A ALA 133 -61.48 -163.66 1 A VAL 136 47.81 114.00 1 A LEU 137 -43.18 167.67 1 A GLN 138 -158.11 86.27 1 A PRO 140 -59.39 -162.65 1 A THR 144 -57.48 -164.65 1 A PRO 146 -59.00 -147.88 1 A LYS 147 -46.16 -86.71 1 A ALA 151 -45.03 165.27 1 A GLU 152 -35.75 -36.68 1 A SER 154 50.38 77.22 minimized average Structure of the N-terminal RNA-binding Domain of the SARS CoV Nucleocapsid Protein 1 N N STRUCTURAL PROTEIN nucleocapsid protein, STRUCTURAL PROTEIN NCAP_CVHSA UNP 1 45 P59595 GLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMKELSPRWYFYYLGTGPEASLPY GANKEGIVWVATEGALNTPKDHIGTRNPNNNAATVLQLPQGTTLPKGFYAEGSRGGS 45 181 1SSK 22 158 P59595 A 1 22 158 1 cloning artifact MET 1 1SSK A P59595 UNP 1 1 cloning artifact GLY 2 1SSK A P59595 UNP 2 1 cloning artifact SER 3 1SSK A P59595 UNP 3 1 cloning artifact SER 4 1SSK A P59595 UNP 4 1 expression tag HIS 5 1SSK A P59595 UNP 5 1 expression tag HIS 6 1SSK A P59595 UNP 6 1 expression tag HIS 7 1SSK A P59595 UNP 7 1 expression tag HIS 8 1SSK A P59595 UNP 8 1 expression tag HIS 9 1SSK A P59595 UNP 9 1 expression tag HIS 10 1SSK A P59595 UNP 10 1 cloning artifact SER 11 1SSK A P59595 UNP 11 1 cloning artifact SER 12 1SSK A P59595 UNP 12 1 cloning artifact GLY 13 1SSK A P59595 UNP 13 1 cloning artifact LEU 14 1SSK A P59595 UNP 14 1 cloning artifact VAL 15 1SSK A P59595 UNP 15 1 cloning artifact PRO 16 1SSK A P59595 UNP 16 1 cloning artifact ARG 17 1SSK A P59595 UNP 17 1 cloning artifact GLY 18 1SSK A P59595 UNP 18 1 cloning artifact SER 19 1SSK A P59595 UNP 19 1 cloning artifact ALA 20 1SSK A P59595 UNP 20 1 initiating methionine MET 21 1SSK A P59595 UNP 21 5 anti-parallel anti-parallel anti-parallel anti-parallel A ILE 108 A ILE 108 A VAL 111 A VAL 111 A ILE 62 A ILE 62 A ALA 68 A ALA 68 A ARG 85 A ARG 85 A LEU 91 A LEU 91 A ALA 33 A ALA 33 A GLN 36 A GLN 36 A PHE 149 A PHE 149 A TYR 150 A TYR 150